Toxicity of 3,3',4,4'-tetrachloroazoxybenzene in rats and mice

Toxicology and Applied Pharmacology

Volumn 156, Issue 3, 1999, Pages 206-221

  Van Birgelen, Angélique P J M ^a   Hébert, Charles D ^a   Wenk, Martin L ^b   Grimes, Linda K ^c   Chapin, Robert E ^a   Travlos, Greg S ^a   Mahler, Joel ^a   Bucher, John R ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b MA BioServices Inc   (United States)

^c Environmental Health Research and Testing   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENE DERIVATIVE; THYROXINE;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CELL HYPERPLASIA; CELL PROLIFERATION; ESTRUS CYCLE; FEMALE; HEMATOPOIETIC CELL; HISTOPATHOLOGY; KIDNEY DISEASE; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; PNEUMONIA; RAT; SPERMATOZOON MOTILITY; THYMUS; THYROXINE BLOOD LEVEL; TOXICITY; WEIGHT REDUCTION;

ANIMALIA;

EID: 0345211512     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1999.8647     Document Type: Article

References (91)

1. Adams E. M., Irish D. D., Spencer H. C., Rowe V. K. The response of mouse skin to compounds reported to have caused acneform dermatitis. Ind. Med. Ind. Hyg. 2:1941;1-4.
2. Allen J. R., Barsotti D. A., Van Miller J. P., Abrahamson L. J., Lalich J. J. Morphological changes in monkeys consuming a diet containing low levels of 2,3,7,8-tetrachlorodibenzo-p. Food Cosmet. Toxicol. 15:1977;401-410.
3. Allen J. R., Carstens L. A. Light and electronic microscopic observations inMacaca mulata. Am. J. Vet. Res. 28:1967;1513-1526.
4. Barter R. A., Klaasen C. D. UDP-glucuronosyltransferase inducers reduce thyroid hormone levels in rats by an extrathyroidal mechanism. Toxicol. Appl. Pharmacol. 113:1992;36-42.
5. Bastomski C. H. Enhanced thyroxine metabolism and high uptake goiters after a single dose of 2,3,7,8-tetrachlorodibenzo-p. Endocrinology. 101:1977;292-296.
6. Birnbaum L. S. Evidence for the role of the Ah receptor in response to dioxin. Receptor-mediated Biological Processes: Implications for Evaluating Carcinogenesis. Progress in Clinical and Biological Research. 1994;Wiley-Liss, New York. p. 139-154.
7. Bleavins M. R., Hinsdill R. D., Hochstein J. R., Hsia M. T. S. Effects of 3,3′,4,4′-tetracholoroazoxybenzene on selected immune parameters of the mouse. Arch. Environ. Contam. Toxicol. 14:1985a;669-676.
8. Bleavins M. R., Hinsdill R. D., Hsia M. T. S., Meisner L. F., Wiley J. E. Reproductive, immunologic, and cytogenetic effects of dietary 3,3′,4,4′-tetrachloroazoxybenzene exposure to mice. Arch. Environ. Contam. Toxicol. 14:1985b;677-684.
9. Bock K. W. Roles of UDP-glucuronosyltransferases in chemical carcinogenesis. Crit. Rev. Biochem. Mol. Biol. 26:1991;129-150.
10. Brandt I., Bergman Å. PCB methyl sulphones and related compounds: Identification of target cells and tissues in different species. Chemosphere. 16:1987;1671-1676.
11. Brouwer A., Blaner W. S., Kukler A., van den Berg K. J. Study on the mechanism of interference of 3,4,3′,4′-tetrachlorobiphenyl with the plasma retinol-binding proteins in rodents. Chem. Biol. Interact. 68:1988;203-217.
12. Brouwer A., van den Berg K. J. Binding of a metabolite of 3,4,3′,4′-tetrachlorobinphenyl to transthyretin reduces serum vitamin A transport by inhibiting the formation of the protein complex carrying both retinol and thyroxin. Toxicol. Appl. Pharmacol. 85:1986;301-312.
13. Brown H. R., Hardisty J. F. Oral cavity, esophagus, and stomach. Boorman G. A., Eustis S. L., Elwell M. R., Montgomery C. A. Jr., MacKenzie W. F. Pathology of the Fischer Rat. 1990;9-30 Academic Press, San Diego.
14. Butler W. H. A review of the hepatic tumors related to mixed-function oxidase induction in the mouse. Toxicol. Pathol. 24:1996;484-492.
15. Chapin R. E., Sloane R. A., Haseman J. K. The relationships among reproductive endpoints in Swiss mice, using the reproductive assessment by continuous breeding database. Fundam. Appl. Toxicol. 38:1997;129-142.
16. De Waal E. J., Schuurman H.-J., Van Loveren H., Vos J. G. Differential effects of 2,3,7,8-tetrachlorodibenzo-pbisN. Crit. Rev. Toxicol. 27:1997;381-430.
17. Dhur A., Galan P., Hercberg S. Effects of different degrees of iron deficiency on cytochrome P450 complex and pentose phosphate pathway dehydrogenases in the rat. J. Nutr. 119:1989;40-47.
18. Dunn O. J. Multiple comparisons using rank sums. Technometrics. 6:1964;241-252.
19. Dunnett C. W. A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 50:1955;1096-1121.
20. Gart J. J., Chu K. C., Tarone R. E. Statistical issues in interpretation of chronic bioassay tests for carcinogenicity. J. Natl. Cancer Inst. 62:1979;957-974.
21. Gray L. E. Jr., Ostby J. S., Kelce W. R. A dose-response analysis of the reproductive effects of a single gestational dose of 2,3,7,8-tetrachlorodibenzo-p. Toxicol. Appl. Pharmacol. 146:1997;11-20.
22. Gray L. E. Jr., Ostby J., Marshall R., Andrews J. Reproductive and thyroid effects of low-level polychlorinated biphenyl (Aroclor 1254) exposure. Fundam. Appl. Toxicol. 20:1993;288-294.
23. Grossman S., Budinsky R., Jollow D. Dapsone-induced hemolytic anemia: Role of glucose-6-phosphate dehydrogenase in the hemolytic response of rat erythrocytes toN. J. Pharmacol. Exp. Ther. 273:1995;870-877.
24. Gupta B. N., Vos J. G., Moore J. A., Zinkl J. G., Bullock B. C. Pathologic effects of 2,3,7,8-tetrachlorodibenzo-p. Environ. Health Perspect. 5:1973;125-140.
25. Hassoun E., d'Argy R., Dencker L., Sundström G. Teratological studies on the TCDD congener 3,3′4,4,′-tetrachloroazoxybenzene in sensitive and nonsensitive mouse strains: Evidence for direct effect on embryonic tissues. Arch. Toxicol. 55:1984;20-26.
26. Hayashi Y., Kokubo T., Takahashi M., Furukawa F., Otsuka H., Hashimoto K. Correlative morphological and biochemical studies on monocrotaline-induced pulmonary alterations in rats. Toxicol. Lett. 21:1984;65-71.
27. Hébert C. D., Harris M. W., Elwell M. R., Birnbaum L. S. Relative toxicity and tumor-promoting ability of 2,3,7,8-tetrachlorodibenzo-p. Toxicol. Appl. Pharmacol. 102:1990;362-377.
28. Henry E. C., Gasiewicz T. A. Effects of thyroidectomy on theAhp. Chem.-Biol. Interact. 59:1986;29-42.
29. Hill R. J. Jr., Rollen Z. J., Kimbrough R. D., Groce D. F., Needham L. L. Tetrachloroazobenzene in 3,4-dichloroaniline and its herbicidal derivatives; Propanil, diuron, linuron, and neburon. Arch. Environ. Health. 36:1981;11-14.
30. Horton V. L., Yeary R. A. Assessment of the chloracnegenic response induced by 3,3′,4,4′-tetrachloroazoxybenzene in mice. J. Toxicol. Environ. Health. 15:1985;215-227.
31. Hsia M. T. S., Burant C. F., Kreamer B. L., Schrankel K. R. Thymic atrophy induced by acute exposure of 3,3′,4,4,′-tetrachloroazobenzene and 3,3′,4,4′-tetrachloroazoxybenzene in rats. Toxicology. 24:1982;231-244.
32. Hsia M. T. S., Kreamer B. L. Delayed wasting syndrome and alterations of liver gluconeogenic enzymes in rats exposed to the TCDD congener 3,3′,4,4′-tetrachloroazoxybezene. Toxicol. Lett. 25:1985;247-258.
33. Hsia M. T. S., Kreamer B. L., Burant C. F., Treutelaar M. K. General health effects of prolonged exposure to 3,3′,4,4′-tetrachloroazobenzene and 3,3′,4,4′-tetrachloroazoxybenzene in rats. Drug Chem. Toxicol. 3:1980;47-56.
34. Hsia M. T. S., Schrankel K. R., Burant C. F., Kreamer B. L. Mammalian pathotoxicology of 3,3′,4,4′-tetrachloroazobenzene and 3,3′,4,4′-tetrachloroazoxybene. Trace Subst. Environ. Health. 15:1981;238-246.
35. Jain N. C. Hemolytic anemias of noninfectious origin. Schalm's Veterinary Hematology. 1986;Lea and Febiger, Philadelphia. p. 627-654.
36. Jonckheere A. R. A distribution-freek. Biometrika. 41:1954;133-145.
37. Kafafi S. A., Afeefy H. Y., Ali A. H., Said H. K., Abd-Elazem I. S., Kafafi A. G. Affinities for the aryl hydrocarbon receptor, potencies as aryl hydrocarbon hydroxylase inducers and relative toxicities of polychlorinated biphenyls. A congener specific approach. Carcinogenesis. 14:1993;2063-2071.
38. Kanno H., Morimoto M., Fujii H., Tsujimura T., Asai H., Noguchi T., Kitamura Y., Miwa S. Primary structure of murine red blood cell-type pyruvate kinase (PK) and molecular characterization of PK deficiency identified in the CBA strain. Blood. 86:1995;3205-3210.
39. Kato Y., Haraguchi K., Shibahara T., Yumoto S., Masuda Y., Kimura R. Reduction of thyroid hormone levels by methysulfonyl metabolites of polychlorinated biphenyl congeners in rats. Organohalogen Compnd. 37:1998;245-248.
40. Kaufman D. D., Plimmer J. R., Iwan J., Klingebiel U. I. 3,3′,4,4′-Tetrachloroazoxybenzene form 3,4-dichloroaniline in microbial culture. J. Agric. Food Chem. 20:1972;916-919.
41. Knutson J. C., Poland A. Response of murine epidermis to 2,3,7,8-tetrachlorodibenzo-pAhhr. Cell. 30:1982;225-234.
42. Kociba R. J., Keeler P. A., Park C. N., Gehring P. J. 2,3,7,8-Tetrachlorodibenzo-p. Toxicol. Appl. Pharmacol. 35:1976;553-574.
43. Kociba R. J., Keyes D. G., Beyer J. E., Carreon R. M., Wade C. E., Dittenber D. A., Kalnins R. P., Frauson L. E., Park C. N., Barnard S. D., Hummel R. A., Humiston C. G. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p. Toxicol. Appl. Pharmacol. 46:1978;279-303.
44. Kujawa M., Macholz R., Härtig M., Plass R., Nickel B. Verteilung und Metabolismus von Azoxybenzen in der Ratte. Z. Gesamte Hyg. 35:1989;255-257.
45. Kuratsune M. Kimbrough R. D., Jensen A. A. Halogenated Biphenyls, Terphenyls, Naphthalenes, Dibenzodioxins, and Related Products. 1989;381-400 Elsevier Science Publishes, New York.
46. Lalich J. J., Ehrhart L. A. Monocrotaline-induced pulmonary arteritis in rats. J. Atheroscler. Res. 2:1962;482-492.
47. Lans M. C., Klasson-Wehler E., Willemsen M., Meussen E., Safe S., Brouwer A. Structure-dependent, competitive interaction of hydroxy-polychlorobiphenyls, -dibenzo-p. Chem.-Biol. Interact. 88:1993;7-21.
48. Li X., Johnson D. C., Rozman K. K. Effects of 2,3,7,8-tetrachlorodibenzo-p. Toxicol. Lett. 78:1995;219-222.
49. Lund B.-O., Bergman Å., Brunström B., Örberg J. Accumulation and long term effects of a PCB and DDE methyl sulfone mixture in the mink (Mustela vison. Organohalogen Compnd. 33:1997;360-365.
50. Mably T. A., Bjerke D. L., Moore R. W., Gendron-Fitzpatrick A., Peterson R. E. In uterop. Toxicol. Appl. Pharmacol. 114:1992;118-126.
51. Mansour M., Parlar H., Korte F. Beiträge zur Ökologischen Chemie Ci. Reaktionsverhalten von 3,4 Dichloranilin und 3,4 Dichlorphenol in Lösung, als Festkörper und in der Gasphase bei Uv-Bestrahlung. Chemosphere. 4:1975;235-240.
52. McConnell E. E., Moore J. A., Dalgard D. W. Toxicity of 2,3,7,8-tetracholorodibenzo-pMacaca mulatta. Toxicol. Appl Pharmacol. 43:1978;175-187.
53. McKinney J. D., Fawkes J., Jordan S., Chae K., Oatley S., Coleman R. E., Briner W. 2,3,7,8-Tetrachlorodibenzo-p. Environ. Health Perspect. 61:1985;41-53.
54. McMillan D. C., Leaky J. E. A., Arlotto M. P., McMillan J. M., Hinson J. A. Metabolism of the arylamide herbicide propanil. II. Effects of propanil and its derivatives on hepatic microsomal drug-metabolizing enzymes in the rats. Toxicol. Appl. Pharmacol. 103:1990;102-112.
55. Meyrick B., Gamble W., Reid L. Development ofCrotalaria. Am. J. Physiol. 239:1980;H692-H702.
56. Miller J. W. Pathologic changes in animals exposed to a commercial chlorinated mixture of diphenyl. Public Health Rep. 59:1994;1085-1093.
57. Montgomery C. A. Jr., Seely J. C. Kidney. Boorman G. A., Eustis S. L., Elwell M. R., Montgomery C. A. Jr., MacKenzie W. F. Pathology of the Fischer Rat. 1990;127-153 Academic Press, San Diego.
58. Morrison D. F. Multivariate Statistical Methods. 1976;McGraw-Hill Book Company, New York. p. 170-179.
59. Morrissey R., Schwetz B., Lamb J. IV, Ross M., Teague J., Morris R. Evaluation of rodent cytology, and reproductive organ weight data from National Toxicology Program thirteen-week studies. Fundam Appl. Toxicol. 11:1988;343-358.
60. Morse D. C., Groen D., Veerman M., Van Amerongen C. J., Koëter H. B. W. M., Smits Van Prooije A. E., Visser T. J., Koeman J. H., Brouwer A. Interference of polychlorinated biphenyls in hepatic and brain thyroid hormone metabolism in fetal and neonatal rats. Toxicol. Appl. Pharmacol. 122:1993;27-33.
61. National Toxicology Program (NTP), 1982, Carcinogenesis Bioassay of 2,3,7,8-Tetrachlorodibenzo-p, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, NC.
62. 1, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, NC.
63. 1, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, NC.
64. Olson L. J., Hsia M. T. S., Kreamer B. L., Hinsdill R. D. Immunosuppression in weanling and adult Sprague-Dawley rats induced by acute exposure to 3,3′,4,4′-tetrachloroazoxybenzene. Toxicology. 32:1984;287-296.
65. Pillai U. A., Ziegler T. L., Wang D. X., Kattnig M. J., McClure T., Liebler D. C., Mayersohn M., Sipes I. G. 3,3′,4,4′-Tetrachloroazobenzene absorption, disposition, and metabolism in male Fischer 344 rats. Drug. Metab. Dispos. 24:1996;238-244.
66. Plüss N., Poiger H., Hohbach C., Suter M., Schlatter C. Subchronic toxicity of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) in rats. Chemosphere. 17:1988;1099-1110.
67. Poland A., Glover E., Kende A. S., DeCamp M., Giandomenico C. M. 3,4,3′,4′-Tetrachloro azoxybenzene and azobenzene: Potent inducers of aryl hydrocarbon hydroxylase. Science. 194:1976;627-630.
68. Poland A., Palen D., Glover E. Tumour promotion by TCDD in skin of HRS/J hairless mice. Nature. 300:1982;271-273.
69. Reindel J. F., Ganey P. E., Wagner J. G., Slocombe R. F., Roth R. A. Development of morphologic, hemodynamic, and biochemical change in lungs of rats given monocrotaline pyrrole. Toxicol. Appl. Pharmacol. 106:1990;179-220.
70. Safe S. Polychlorinated biphenyls (PCBs), dibenzo-p. Crit. Rev. Toxicol. 21:1990;51-88.
71. Schneider U. A., Brown M. M., Logan R. A., Millar L. C., Bunce N. J. Screening assay for dioxin-like compounds based on competitive binding to the murine hepatic Ah receptor. 1. Assay development. Environ. Sci. Technol. 29:1995;2595-2602.
72. Schrankel K. R., Hsia M. T. S., Pounds J. G. Hepatocellular pathotoxicology of 3,3′,4,4′-tetrachloroazobenzene and 3,3′,4,4′-tetrachloroazoxybenzene in the rodent. I.In vivo. Res. Commun. Chem. Pathol. Pharmacol. 28:1980;527-540.
73. Schrankel K. R., Kreamer B. L., Hsia M. T. S. Embryotoxicity of 3,3′,4,4′-tetrachloroazobenzene and 3,3′,4,4′-tetrachloroazoxybenzene in the chick embryo. Arch. Environ. Contam. Toxicol. 11:1982;195-202.
74. Schrenk D., Lipp H.-P., Wiesmuller T., Hagenmaier H., Bock K. W. Assessment of biological activities of mixtures of polychlorinated dibenzo-p. Arch. Toxicol. 65:1991;114-118.
75. Shirley E. A non-parametric equivalent of Williams' test for contrasting increasing dose levels of a treatment. Biometrics. 33:1977;386-389.
76. Sommer R. J., Ippolito D. L., Peterson R. E. In uterop. Toxicol. Appl. Pharmacol. 140:1996;146-153.
77. Sundström G., Jansson B., Renberg L. Determination of the toxic impurities 3,3′,4,4′-tetrachloroazobenzene and 3,3′,4,4′-tetrachloroazoxybenzene in commercial diuron, linuron and 3,4-dichloroaniline samples. Chemosphere. 12:1978;973-979.
78. Taylor J. S., Wuthrich R. C., Lloyd K. M., Poland A. Chloracne from manufacture of a new herbicide. Arch. Dermatol. 113:1977;616-619.
79. Van Birgelen A. P. J. M., Smith E. A., Kampen I. M., Groeneveld C. N., Fase K. M., Van der Kolk J., Poiger H., Van den Berg M., Koeman J. H., Brouwer A. Subchronic effects of 2,3,7,8-TCDD or PCBs on thyroid hormone metabolism: Use in risk assessment. Eur. J. Pharmacol. 293:1995;77-85.
80. Van Miller J. P., Lalich J. J., Allen J. R. Increased incidence of neoplasms in rats exposed to low levels of 2,3,7,8-tetrachlorodibenzo-p. Chemosphere. 10:1977;625-632.
81. Vié M.-P., Blanchet P., Samson M., Francon J., Blondeau J.-P. High affinity thyroid hormone-binding protein in human kidney: Kinetic characterization and identification by photoaffinity labeling. Endocrinology. 137:1996;4563-4570.
82. Viluksela M., Stahl B. U., Birnbaum L. S., Schramm K.-W., Kettrup A., Rozman K. K. Subchronic/chronic toxicity of 1,2,3,4,6,7,8-heptachlorodibenzo-p. Toxicology. Appl. Pharmacol. 146:1997;207-216.
83. Von Wedel H., Holla W. A., Denton J. Observations on the toxic effects resulting from exposure to chlorinated naphthalene and chlorinated phenyls with suggestions for prevention. Rubber Age (New York). 53:1943;419-426.
84. Vos J. G., Beems R. B. Dermal toxicity studies of technical polychlorinated biphenyls and fractions thereof in rabbits. Toxicol. Appl. Pharmacol. 19:1971;617-633.
85. Vos J. G., Van Leeuwen F. X. R., De Jong P. Acnegenic activity of 3-methylcholanthrene and benzo[ap. Toxicology. 23:1982;187-196.
86. Waalkens-Berendsen D. H., Smits-Van Prooije A. E., Snoeij N. J., Dijkstra A. Cross-fostering study with PCB 169 (3,3′,4,4′,5,5′-hexachlorobiphenyl) in Wistar rats. Teratology. 50:1994;35A.
87. Weissberg J. B., Zinkl J. G. Effects of 2,3,7,8-tetrachlorodibenzo-p. Environ. Health Perspect. 5:1973;119-123.
88. Williams D. A. A test for differences between treatment means when several dose levels are compared with a zero dose control. Biometrics. 27:1971;103-117.
89. Williams D. A. The comparison of several dose levels with a zero dose control. Biometrics. 28:1972;519-531.
90. Ziegler T. L., Pillai U. A., Smith R. L., Kattnig M. J., Liebler D. C., Mayersohn M., Sipes I. G. Absorption and disposition kinetics of 3,3′,4,4′-tetrachloroazoxybenzene in the male Fischer 344 rat. Drug. Metab. Dispos. 24:1996;1009-1014.
91. Zinkl J. G., Vos J. G., Moore J. A., Gupta B. N. Hematologic and clinical chemistry effects of 2,3,7,8-tetrachlorodibenzo-p. Environ. Health Perspect. 5:1973;111-118.